Top Doctor: Dr. Stuart Gordon
Dr. Gordon is Professor of Medicine, Wayne State University School of Medicine and Director, Division of Hepatology, Henry Ford Hospital. He received his training in clinical hepatology at the University of Miami, under Drs. Leon and Eugene Schiff. He has authored or coauthored over 350 papers, reviews, editorials, and book chapters, and was identified by Clarivate Analytics among the most highly cited researchers globally. He serves as ad-hoc member on several NIH and NCI Study Sections, is on the data and monitoring board for the Drug Induced Liver Injury Network (DILIN), is on the Global NASH Council and serves on the Board of Directors for Liver Health International.
Dr. Gordon was the recipient of the Distinguished Alumni Award from Wayne State University School of Medicine and is a Laureate of the Michigan Chapter of the American College of Physicians. He was an appointed member of the AASLD-IDSA Hepatitis C Guidance Committee and served on the editorial board of Clinical Gastroenterology and Hepatology.
In collaboration with the Centers for Disease Control, Dr. Gordon was the Principal Investigator of the multicenter CHeCS (Chronic Hepatitis Cohort Study) that examined the health burden, natural history, epidemiology and treatment challenges posed by chronic viral hepatitis in the United States. He was also the Principal Investigator of the Fibrotic Liver Disease consortium of 11 US medical centers that collectively serve 4.2 million patients. This group examines the prevalence, natural history, treatment uptake/response, and clinical outcomes of patients with primary biliary cholangitis (PBC) in the United States.
